Serum Insulin-like Factor 3 Levels Are Reduced in Former Androgen Users, Suggesting Impaired Leydig Cell Capacity.
Jon Jarløv RasmussenJakob AlbrethsenMikkel Nicklas FrandsenNiels JørgensenAnders JuulCaroline KistorpPublished in: The Journal of clinical endocrinology and metabolism (2021)
Serum INSL3 is reduced years following AAS cessation in men, independently of testosterone, suggesting persistently impaired Leydig cell capacity.